Cardiovascular risk prevention and all-cause mortality in primary care patients with an abdominal aortic aneurysm

British Journal of Surgery

Volumn 103, Issue 12, 2016, Pages 1626-1633

  Bahia, S S ^a   Vidal Diez, A ^a   Seshasai, S R K ^a   Shpitser, I ^c   Brownrigg, J R ^a   Patterson, B O ^a   Ray, K K ^b   Holt, P J ^a   Thompson, M M ^a   Karthikesalingam, A ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; CARDIOTONIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ABDOMINAL AORTA ANEURYSM; AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COMPLICATION; FEMALE; HUMAN; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; RISK ASSESSMENT; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; AORTIC ANEURYSM, ABDOMINAL; CARDIOTONIC AGENTS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RISK ASSESSMENT;

EID: 84994155230     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.10269     Document Type: Article

References (25)

1. European Society for Vascular Surgery. Second Vascular Surgery Database Report; 2008. http://www.e-dendrite.com/files/13/file/Pages%20from%20VNET%202008.pdf [accessed 21 June 2016].
2. Waton S, Johal A, Groene O, Cromwell D, Mitchell D, Loftus IM. Outcomes After Elective Repair of Infra-renal Abdominal Aortic Aneurysm. Royal College of Surgeons of England: London, 2013. https://www.vsqip.org.uk/content/uploads/2013/11/Outcomes-after-Elective-Repair-of-Infra-renal-Abdominal-Aortic-Aneurysm.pdf [accessed 21 June 2016].
3. Norman PE, Semmens JB, Lawrence-Brown MM, Holman CD. Long term relative survival after surgery for abdominal aortic aneurysm in Western Australia: population based study. BMJ 1998; 317: 852–856.
4. Norman PE, Semmens JB, Lawrence-Brown MM. Long-term relative survival following surgery for abdominal aortic aneurysm: a review. Cardiovasc Surg 2001; 9: 219–224.
5. Karthikesalingam A, Bahia SS, Patterson BO, Peach G, Vidal-Diez A, Ray KK et al. The shortfall in long-term survival of patients with repaired thoracic or abdominal aortic aneurysms: retrospective case–control analysis of hospital episode statistics. Eur J Vasc Endovasc Surg 2013; 46: 533–541.
6. Lloyd GM, Newton JD, Norwood MG, Franks SC, Bown MJ, Sayers RD. Patients with abdominal aortic aneurysm: are we missing the opportunity for cardiovascular risk reduction? J Vasc Surg 2004; 40: 691–697.
7. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C et al.; Cholesterol Treatment Trialists (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet 2005; 366: 1267–1278.
8. Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Erqou S, Sattar N et al. Effect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trials. Arch Intern Med 2012; 172: 209–216.
9. Bangalore S, Kumar S, Volodarskiy A, Messerli FH. Blood pressure targets in patients with coronary artery disease: observations from traditional and bayesian random effects meta-analysis of randomised trials. Heart 2013; 99: 601–613.
10. Moll FL, Powell JT, Fraedrich G, Verzini F, Haulon S, Waltham M et al. Management of abdominal aortic aneurysms clinical practice guidelines of the European Society for Vascular Surgery. Eur J Vasc Endovasc Surg 2011; 41: S1–S58.
11. Keil AP, Edwards JK, Richardson DB, Naimi AI, Cole SR. The parametric g-formula for time-to-event data: intuition and a worked example. Epidemiology 2014; 25: 889–897.
12. Carey IM, Shah SM, Harris T, DeWilde S, Cook DG. A new simple primary care morbidity score predicted mortality and better explains between practice variations than the Charlson index. J Clin Epidemiol 2013; 66: 436–444.
13. Cole SR, Hernán MA. Adjusted survival curves with inverse probability weights. Comput Methods Programs Biomed 2004; 75: 45–49.
14. Simon R, Makuch RW. A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-responder bias. Stat Med 1984; 3: 35–44.
15. Robins JM, Greenland S. The role of model selection in causal inference from nonexperimental data. Am J Epidemiol 1986; 123: 392–402.
16. VanderWeele TJ, Hernan MA, Robins JM. Causal directed acyclic graphs and the direction of unmeasured confounding bias. Epidemiology 2008; 19: 720–728.
17. Moran GM, Calvert M, Feltham MG, Marshall T. Retrospective case review of missed opportunities for primary prevention of stroke and TIA in primary care: protocol paper. BMJ Open 2014; 4: e006622.
18. United Kingdom EVAR Trial Investigators, Greenhalgh RM, Brown LC, Powell JT, Thompson SG, Epstein D, Sculpher MJ. Endovascular versus open repair of abdominal aortic aneurysm. N Engl J Med 2010; 362: 1863–1871.
19. Cannon CP, Steinberg BA, Murphy SA, Mega JL, Braunwald E. Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. J Am Coll Cardiol 2006; 48: 438–445.
20. Cholesterol Treatment Trialists' (CTT) Collaboratos, Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 2012; 380: 581–590.
21. Stone NJ, Robinson J, Lichtenstein AH, Merz CN, Blum CB, Eckel RH et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2014; 129(Suppl 2): S1–S45.
22. Antithrombotic Trialists' (ATT) Collaboration, Baigent C, Blackwell L, Collins R, Emberson J, Godwin J et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009; 373: 1849–1860.
23. Smith SC Jr, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA et al.; World Heart Federation and the Preventive Cardiovascular Nurses Association. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011; 124: 2458–2473.
24. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903–1913.
25. James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014; 311: 507–520.